Term ended no later than Feb 14, 2025 · Low confidence
20-year base term ended Feb 14, 2025
Feb 14, 2005
Feb 14, 2025
Aug 25, 2009
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 14, 2005, when application 11/058,134, the earliest non-provisional in its chain, was filed (this one was filed Feb 14, 2006); a parent in its chain could not be resolved (the next row) | Feb 14, 2025 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | no later than Feb 14, 2025 | Low confidence |
This family
| US 7,803,931 | Term ended Feb 2025 | Feb 2025 |
| US 7,538,211 | Term ended Feb 2025 | Feb 2025 |
| US 7,579,456 | this patent no later than Feb 2025 | no later than Feb 2025 |
| US 8,236,773 | Term ended Nov 2026 | Nov 2026 |
| US 8,436,164 | Term ended Feb 2025 | Feb 2025 |
| US 9,617,546 | Term ended no later than Feb 2025 | no later than Feb 2025 |
| US 10,947,544 | Term ended Feb 2025 | Feb 2025 |
| US 11,913,000 | Term ended Apr 2025 | Apr 2025 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 8, 2009 Reel 22792, frame 53 | Benedict, Claude; Epstein, David; Kurz, Jeffrey; Kurz, Markus; McCauley, Thomas Greene; McCauley, Dilara; Rottman, James; Wilson, Charles | Archemix Corp. | Assignment of Assignor's Interest |
| Jan 10, 2012 Reel 27510, frame 478 | Archemix Corp. | Archemix LLC | Merger |
| Aug 5, 2022 Reel 61088, frame 48 | Iveric Bio, Inc. | Hercules Capital, Inc. | Security Interest |
| Jul 17, 2023 Reel 64286, frame 472 | Hercules Capital, Inc. | Iveric Bio, Inc.; Iveric Bio Gene Therapy LLC; Orion Ophthalmology LLC | Release of Security Interest |
| Jul 17, 2023 reel/frame not recorded | Hercules Capital, Inc. | Iveric Bio, Inc. | Release of Security Interest |
| Jul 17, 2023 reel/frame not recorded | Hercules Capital, Inc. | Iveric Bio Gene Therapy LLC | Release of Security Interest |
| Jul 17, 2023 reel/frame not recorded | Hercules Capital, Inc. | Orion Ophthalmology LLC | Release of Security Interest |
| Sep 5, 2023 Reel 64797, frame 452 | Archemix LLC | Iveric Bio., Inc. | Assignment of Assignor's Interest |
| Jun 26, 2024 Reel 67851, frame 643 | Iveric Bio, Inc. | Astellas US LLC | Merger |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Feb 14, 2025. We will not guess the cap.